Abstract: An electrolyte includes at least one lithium salt, at least one first organic solvent having a dielectric constant of >90 at 40° C., at least one second organic solvent having a boiling point of <110° C., and at least one phosphite having the formula (I) R1 is selected from an n-propoxy group, an iso-propoxy group, a tert-butoxy group, an n-pentafluoropropoxy group, an n-trifluoropropoxy group, an iso-hexafluoropropoxy group, or a tert-nonafluorobutoxy group. R2, R3, R4, and R5 are each selected, independently of one another, from H, a trifluoromethyl group, or a C2-C6-alkyl group which is substituted with a trifluoromethyl group.

Abstract: A method of using a boron cluster as a transmembrane carrier to transport a bioactive molecule across a membrane of a cell or a vesicle. The method includes providing a boron cluster having at least one hydrogen atom and/or at least one halogen atom, providing a bioactive molecule which is cationic, zwitterionic or not charged, so that the bioactive molecule is not negatively charged, and using the boron cluster as a transmembrane carrier to transport the bioactive molecule across the membrane of the cell or the vesicle.

Abstract: A method for producing an examination reagent includes adding a helper ligand to a receptor protein which is unfolded in an initial solution so as to provide a pre-solution of the examination reagent with a receptor protein which is folded. The receptor protein which is folded comprises a bonded helper ligand which can be exchanged with an examination peptide.

Abstract: An imidazolidinylide compound for use as a shut-down additive for a lithium-ion battery. The imidazolidinylide compound has a formula (I), wherein, R1 to R4, each independently the other, is a linear C1- to C16-alkyl group, a branched C1- to C16-alkyl group, a C2- to C16-alkenyl group, a C3- to C8-cycloalkyl group, or a C3- to C16-arene group, wherein at least one of R2 and R3 may also be H, R1 to R4, each independently of the other, is completely, partially or not fluorinated, and R1 to R3 may each also contain O as a heteroatom.

Abstract: A method for detecting T cells includes a first step of bringing a plurality of different antigenic peptides into contact with peptide-free MHC molecules which are arranged in an immobilized manner on a substrate in an array so that the plurality of different antigenic peptides bind to the peptide-free MHC molecules so as to form peptide-loaded MHC molecules, a second step of bringing a sample comprising the T cells into contact with the peptide-loaded MHC molecules on the substrate, and a third step of detecting the binding of the T cells to the peptide-loaded MHC molecules on the substrate.

Abstract: An electrolyte includes at least one lithium salt, at least one first organic solvent having a dielectric constant of >90 at 40° C., at least one second organic solvent having a boiling point of <110° C., and at least one phosphite having the formula (I) R1 is selected from an n-propoxy group, an iso-propoxy group, a tert-butoxy group, an n-pentafluoropropoxy group, an n-trifluoropropoxy group, an iso-hexafluoropropoxy group, or a tert-nonafluorobutoxy group. R2, R3, R4, and R5 are each selected, independently of one another, from H, a trifluoromethyl group, or a C2-C6-alkyl group which is substituted with a trifluoromethyl group.

Abstract: A method for producing an examination reagent includes adding a helper ligand to a receptor protein which is unfolded in an initial solution so as to provide a pre-solution of the examination reagent with a receptor protein which is folded. The receptor protein which is folded comprises a bonded helper ligand which can be exchanged with an examination peptide.

Abstract: A method for producing an examination reagent includes adding a helper ligand to an unfolded receptor protein in an initial solution so as to provide a pre-solution of the examination reagent with a folded receptor protein. The folded receptor protein comprises a bonded helper ligand which can be exchanged with an examination peptide.

Abstract: The present invention provides a compound with a general formula (I) or a salt thereof, wherein, R1 and R2, are, independently of each other, F or CnF2n+1 with n=1-10, and R3 and R4 are, independently of each other, C1-C10-alkyl.

Abstract: A protein produced by an expression system that includes a nucleic acid sequence that encodes an MHC class I heavy chain. The MHC class I heavy chain comprises an alpha-1 helix and an alpha-2 helix. The nucleic acid sequence has a disulfide bridge formed between the alpha-1 helix and the alpha-2 helix in the MHC class I heavy chain. Amino acid 139 is substituted by a cysteine so as to provide Cys-139. Amino acid 84 is substituted by the cysteine so as to provide Cys-84 or amino acid 85 is substituted by the cysteine so as to provide Cys-85. The disulfide bridge is formed between the alpha-1 helix and the alpha-2 helix in the MHC class I heavy chain between Cys-139 and Cys-84 or between Cys-139 and Cys-85. The protein comprises an anchor element selected from a natural biotinylation sequence, a polyhistidine sequence, or a polyarginine sequence.

Abstract: The invention relates to lithium-2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate, to the use thereof as conductive salt in lithium-based energy accumulators, and ionic liquids comprising 2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate as an anion.

Abstract: Provided are genetic material and nucleic acid sequences useful in increasing yield, biomass, growth rate, vigor, nitrogen use efficiency and/or abiotic stress tolerance, preferably tolerance to nutrient deficiency of a plant. Specifically, the improvement of nitrogen fixation properties in cultivated plants is described.

Abstract: A compound having general formula (I) wherein, R1 and R2 are, independently of each other, CN or NH2, or together form a substituted aromatic ring system or an unsubstituted aromatic ring system. R3 and R4 are, independently of each other, C1-C12-alkyl. R5 is H, a halogen, or CnF2n+1, wherein n=1-10.

Abstract: The present invention provides a compound with a general formula (I) or a salt thereof, wherein, R1 and R2, are, independently of each other, F or CnF2n+1 with n=1-10, and R3 and R4 are, independently of each other, C1-C10-alkyl.

Abstract: The invention relates to lithium-2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate, to the use thereof as conductive salt in lithium-based energy accumulators, and ionic liquids comprising 2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate as an anion.

Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of tumor involving a chromosomal rearrangement, in particular a tumor or neoplasia of the thyroid gland. In addition, methods of identifying anti-tumor agents are described.

Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of gynecological tumors, in particular uterine leiomyoma (UL). Furthermore, novel methods and compositions for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of pituitary and prostate tumors are described.

Abstract: A gene coded for a MHC class I molecule. The MHC class I molecule comprises an ALPHA-1 helix and an ALPHA-2 helix. The gene is coded so that a bond is formed between the ALPHA-1 helix and the ALPHA-2 helix in the MHC class I molecule.

Abstract: The invention describes a composite microfiber, which is comprising a polysaccharide polymer selected from the group consisting of cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl cellulose, ethyl cellulose, n-propyl cellulose, isopropyl cellulose, cellulose acetate and combinations of two or more of these substances, and combinations of two or more of these substances, thereby the polysaccharide polymer further comprising substituents comprising a given formula, wherein k is 1 or greater, and wherein each moiety R1 is independently selected from H and methyl, and wherein each moiety R2 is independently selected from —H, —OH, —NH2, —SH, —OR3, —NHR3 and —NR3R4, —SR3, and wherein each moiety R3 and R4 are chemical groups independently selected from C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkoxy halide and C1-C4 heteroalkyl substituents, and is preferably selected from —CH3, —CH2—CH3, —CH2—OH, —CH2—CH2—OH, —CH2—CH2—NH2, —CH—CH(OH)—CH2—OH, —CH—CH(OH)—CH3, glycidyl, anhydride, sulfonic acid and hydroxys

Abstract: A method of comparing first and second documents, the method comprising determining criteria of the comparison, selecting comparison means based on the criteria from a plurality of comparison means, and performing the comparison of the first and second documents by using the selected comparison means.